Full name
RANDOX LABORATORIES POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
46.19.Z - Activity of agents involved in wholesale trade of non-specialized goods
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.51.Z - Wholesale trade
46.69.Z - Wholesale trade
46.90.Z - Non-specialized wholesale trade
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
72.11.Z - Scientific research and development activities
77 - Rental and leasing
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | -1,9 | -1,9 | -0,8 | 55 |
EBITDA | -1,8 | -1,8 | -0,8 | 57,2 |
Short time liabilities | 10,4 | 11,7 | 13,1 | 12,3 |
Equity capital | -6,5 | -8,4 | -9,3 | -10 |
Operating profit (EBIT) | -1,9 | -1,9 | -0,8 | 55 |
Assets | 3,9 | 3,3 | 3,9 | 18,3 |
Net profit (loss) | -1,9 | -1,9 | -0,8 | 55 |
Cash | 0,5 | 0,6 | 0,6 | -6,1 |
Net income from sale | 6,4 | 7,7 | 8,9 | 16,5 |
Liabilities and provisions for liabilities | 10,4 | 11,7 | 13,1 | 12,3 |
Working assets | 3,8 | 3,2 | 3,8 | 20,3 |
Depreciation | 0 | 0 | 0 | 115,5 |
% | % | % | p.p. | |
Profitability of capital | 28,7 | 22,3 | 9,1 | -13,2 |
Equity capital to total assets | -168,9 | -257,7 | -239,8 | 17,9 |
Gross profit margin | -29,4 | -24,5 | -9,5 | 15 |
EBITDA Margin | -28,8 | -24,2 | -8,9 | 15,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 594 | 557 | 537 | -20 |
Current financial liquidity indicator | 0.3616173267364502 | 0.2723272442817688 | 0.29167410731315613 | 0 |
Net dept to EBITDA | 0.2920764088630676 | 0.32264065742492676 | 0.707746148109436 | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane